A61P 33/12
Schistosomicides
A61P33/12 (Schistosomicides) appears on 309 US grants and 524 published applications in this corpus.
Search patents in A61P- Granted patents
- 309
- Published applications
- 524
- Assignees
- 229
- Inventors
- 964
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 1 |
| 2002 | 4 | 9 |
| 2003 | 5 | 20 |
| 2004 | 5 | 25 |
| 2005 | 7 | 23 |
| 2006 | 9 | 15 |
| 2007 | 9 | 19 |
| 2008 | 9 | 26 |
| 2009 | 15 | 25 |
| 2010 | 15 | 55 |
| 2011 | 16 | 40 |
| 2012 | 23 | 32 |
| 2013 | 21 | 20 |
| 2014 | 15 | 21 |
| 2015 | 14 | 24 |
| 2016 | 21 | 25 |
| 2017 | 16 | 29 |
| 2018 | 20 | 20 |
| 2019 | 15 | 20 |
| 2020 | 15 | 24 |
| 2021 | 11 | 13 |
| 2022 | 7 | 12 |
| 2023 | 9 | 5 |
| 2024 | 5 | 7 |
| 2025 | 4 | 11 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Antibacterial and antiparasitic quinoxaline-2,3-diamine derivatives23 Dec 2025US 12,503,448 B2Aberystwyth University
- Soft chewable pharmaceutical products26 Aug 2025US 12,396,945 B2Intervet Inc.
- Manganese composition for enhancing immunity10 Jun 2025US 12,324,814 B2Peking University
- Vaccine delivery method7 Jan 2025US 12,186,390 B2University of Georgia Research Foundation, Inc.
- Infectious plasmodium sporozoites grown in vitro24 Dec 2024US 12,171,822 B2Sanaria Inc.
- Extruded soft chew containing a non-animal based palatant and active pharmaceutical ingredients14 May 2026US 2026/0130886 A1Virbac
- Recombinant vaccine against helminths in pichia pastoris and methods for producing and purifying proteins for use as vaccines against helminths2 Apr 2026US 2026/0092089 A1FundaçãO Oswaldo Cruz
- Novel Chemotypes for Treating Parasitic Diseases and Methods of Use8 Jan 2026US 2026/0007674 A1The Medical College of Wisconsin, Inc.
- Depsipeptide and uses thereof25 Dec 2025US 2025/0388624 A1NovoBiotic Pharmaceuticals, LLC
- Aryl hydantoin compounds and methods of use20 Nov 2025US 2025/0353819 A1Board of Regents of the University of Nebraska
Most cited
By later US patents
- Downmodulating an immune response with multivalent antibodies to PD-1309US 6,808,710 B1Dana-Farber Cancer Institute, Inc. · 2004
- Anti-PD-L1 antibodies and uses therefor201US 8,552,154 B2Dana-Farber Cancer Institute, Inc. · 2013
- Albumin fusion proteins157US 6,905,688 B2Human Genome Sciences, Inc. · 2005
- PD-1, a receptor for B7-4, and uses therefor156US 7,101,550 B2Dana-Farber Cancer Institute, Inc. · 2006
- Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents135US 7,601,354 B2ImmunoGen, Inc. · 2009